Evaluation of drug intake during pregnancy in the Hungarian Case-Control Surveillance of Congenital Anomalies.

The data of the Hungarian Case-Control Surveillance of Congenital Anomalies, 1980-1987, were evaluated concerning drug intake during pregnancy in 10,698 index patients, 21,546 negative controls, and 828 positive controls (Down syndrome). Excluding pregnancy supplements, the proportion of no drug use was about 30% and the mean number of drugs used was 2.0 in the negative control group. These figures did not differ significantly from data of study and positive control groups. The analysis of most commonly used drugs indicated an extremely high proportion of hormonal support therapy. The teratogenic effect of several human teratogenic drugs was confirmed. However, their use is relatively rare and their attributable risk within the etiology of congenital anomalies is low, at about 0.3-1.0%. At present the teratogenic risk of drugs in humans is exaggerated and it has several unfortunate consequences: negligence in necessary drug use, unnecessary anxiety in pregnant women, and termination of planned pregnancies without any reasonable cause.

[1]  A. Czeizel,et al.  Correlation between the birth prevalence of isolated hypospadias and parental subfertility. , 1990, Teratology.

[2]  A. Czeizel.  OVULATION INDUCTION AND NEURAL TUBE DEFECTS , 1989, The Lancet.

[3]  A. Czeizel.  Teratogenicity of ergotamine. , 1989, Journal of medical genetics.

[4]  B. Källén.  Comments on teratogen update: lithium , 1988 .

[5]  A. Czeizel.  Reserpine is not a human teratogen. , 1988, Journal of medical genetics.

[6]  D. Kennedy,et al.  Prescription drug use before and during pregnancy in a Medicaid population. , 1987, American journal of obstetrics and gynecology.

[7]  P. Rubin.  Prescribing in pregnancy. General principles. , 1986, British medical journal.

[8]  P. Rubin,et al.  Prospective survey of use of therapeutic drugs, alcohol, and cigarettes during pregnancy. , 1986, British medical journal.

[9]  R. Brent.  Editorial comment on comments on "Teratogen update: Bendectin". , 1985, Teratology.

[10]  A. Czeizel,et al.  The load of genetic and partially genetic disorders in man. I. Congenital anomalies: estimates of detriment in terms of years of life lost and years of impaired life. , 1984, Mutation research.

[11]  James G. Wilson.  Environment and birth defects , 1973 .

[12]  A. Czeizel.  A case-control analysis of the teratogenic effects of co-trimoxazole. , 1990, Reproductive toxicology.

[13]  A. Czeizel,et al.  A case-control study to evaluate the risk of congenital anomalies as a result of allylestrenol therapy during pregnancy. , 1988, Clinical therapeutics.

[14]  A. Czeizel.  Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary. , 1987, Reproductive toxicology.